Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Ibotta, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2024
FY2024
FY2025
Revenue
211
320
367
342
Cost of revenue
46.2
44
50.1
71.1
Gross profit
165
276
317
271
Research and development
42.6
50
63.3
61.1
Selling and marketing
110
115
139
119
General and administrative
49.2
51.6
82.7
88.2
Operating expenses
205
220
289
272
Operating income
-40.3
56
27.9
-0.84
Interest expense
6.2
8.8
3.6
0.5
Other non-operating income
-8.98
-5.06
-3.16
-0.09
Pre-tax income
-54.6
44.1
24.5
9.85
Income tax
0.26
5.93
-44.2
6.27
Net income
-54.9
38.1
68.7
3.58
EBITDA
-34
62.7
36
7.48
EPS, basic
-6.33
4.26
2.85
0.13
EPS, diluted
-6.33
1.42
2.56
0.12
Shares, basic (weighted)
8.67
8.95
24.1
28.4
Shares, diluted (weighted)
8.67
26.9
26.9
30.1
Balance sheet
FY2022
FY2024
FY2024
FY2025
Cash and equivalents
17.8
62.6
349
187
Receivables
226
221
209
Other current assets
9.31
11.2
12.6
Total current assets
298
582
408
Property, plant and equipment
2.54
1.95
23.4
Other non-current assets
1.53
0.79
1.08
Total assets
320
678
526
Accounts payable
8.94
7.16
10.8
Accrued liabilities
24.6
18
19.6
Total current liabilities
198
204
208
Long-term debt
64.4
0
Lease liabilities
1.55
0
25.5
Other non-current liabilities
3.86
17
Total liabilities
292
221
238
Total debt
64.4
0
0
Paid-in capital
237
629
692
Retained earnings
-209
-140
-137
Treasury stock
0
-31.3
-268
Shareholders' equity
-34.8
27.9
457
288
Total equity
-34.8
27.9
457
288
Total liabilities and equity
320
678
526
Shares outstanding
9.21
0
Cash flow statement
FY2022
FY2024
FY2024
FY2025
Net income
-54.9
38.1
68.7
3.58
Depreciation and amortization
6.32
6.66
8.08
8.32
Stock-based compensation
6.5
6.99
46.9
44.1
Deferred income tax
0
0
-53.6
3.15
Change in receivables
-34.5
-106
4.4
10.2
Change in payables
-4.53
1.82
-0.91
0.36
Cash from operations
-56.5
22.7
116
95.3
Capital expenditures
-0.79
-0.55
-0.87
-20.3
Purchases of investments
-66
0
0
Cash from investing
-35.7
19.7
-10.2
-34.3
Stock issued
0
0
2.79
9.12
Share buybacks
-0.03
0
-31.3
-233
Cash from financing
74
2.39
181
-224
Net change in cash
-18.1
44.8
287
-163
Free cash flow
-57.3
22.2
115
75
Interest paid
3.52
5.49
2.58
0.25
Income taxes paid
0.07
4.1
13.2
5.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $41.06 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
78.2%
Gross profit / revenue.
Operating margin
-3.5%
Operating income / revenue.
EBITDA margin
-0.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1.3%
Pre-tax income / revenue.
Net margin
-3.2%
Net income / revenue.
FCF margin
21.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
27.2%
Cash from operations / revenue.
Return on equity (ROE)
-4.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-2.3%
Net income / average total assets.
Return on invested capital (ROIC)
-10.1%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
16.9%
Research and development expense / revenue.
Stock-based pay / revenue
15.4%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
5.5%
Capital expenditures / revenue.
D&A / revenue
2.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-6.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
17.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
-14.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
18.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y
-103.0%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-79.2%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-94.8%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-95.3%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-17.8%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-34.8%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-37.1%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-22.5%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
12.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
51.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.71x
Current assets / current liabilities.
Quick ratio
1.65x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.69x
(Cash + short-term investments) / current liabilities.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.47
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$14.74
Revenue / diluted weighted shares.
FCF per share
$3.20
Free cash flow / diluted weighted shares.
Operating cash flow per share
$4.00
Cash from operations / diluted weighted shares.
Book value per share
$10.38
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Share buybacks / free cash flow, when free cash flow is positive.
Valuation
Metric
Value
How it is calculated
Market cap
$951.3M
Share price x shares outstanding.
Enterprise value
$803.2M
Market cap + total debt - cash - short-term investments.
P/S
2.77x
Market cap / revenue.
P/B
3.94x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.94x
Market cap / tangible book value, when positive.
P/FCF
12.8x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
10.2x
Market cap / cash from operations, when positive.
EV/Sales
2.34x
Enterprise value / revenue.
EV/FCF
10.8x
Enterprise value / free cash flow, when both are positive.
FCF yield
7.8%
Free cash flow / market cap.
Earnings yield
-1.2%
Net income / market cap (the inverse of P/E).
Shareholder yield
17.2%
(Dividends paid + share buybacks) / market cap.
What was Ibotta, Inc.'s revenue in fiscal 2025?
Ibotta, Inc. reported revenue of $342.4M for fiscal 2025, 6.8% lower than the year before.
Was Ibotta, Inc. profitable in fiscal 2025?
Yes. Net income was $3.6M, a net margin of 1%.
How much free cash flow did Ibotta, Inc. generate in fiscal 2025?
Cash from operations of $95.3M minus capital expenditures of $20.3M left free cash flow of $75.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.